Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety

NCT07185503 · clinicaltrials.gov ↗

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Mucormycosis in Hematologic Malignancies

Interventions

DRUG: liposomal amphotericin B (3-5 mg/kg/day) combined with posaconazole/isavuconazole

Sponsor

Institute of Hematology & Blood Diseases Hospital, China